Progyny, Inc. (PGNY)

Progyny, Inc. (PGNY) is a healthcare company (healthcare plans) based in the United States. The share price is $36.71, down 1.18% on the day, which values the company at $2.7B. Price as of 18 Nov 2026, 00:15 UTC, from Yahoo Finance.

Key facts

Share price
$36.71−1.18% today
Market value
$2.7B
P/E ratio
33.7×last 12 months
Forward P/E
15.3×
Funk Score
82/100
Against its own history
Well below its usual priceusual price $56.97
200-week average
$27.2735% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Progyny, Inc. in more detail

PGNY trades at 33.7× its last twelve months' earnings, 15.3× next year's expected earnings, 2.0× sales. Measured against its own history, the price is 36% below what its usual multiples would imply ($56.97) — well below its usual price. It sits 35% above its 200-week average of $27.27.

Over the last five fiscal years Progyny, Inc. has compounded revenue 30.2% a year, earnings per share 6.7% a year, free cash flow 40.4% a year. Its Funk Score is 82 out of 100 (financial strength 8.9, profitability 6.3, growth 8.6, value 8.9, each out of 10).

In its favour: Altman Z in the safe zone; Operating margin is expanding.

Progyny, Inc. (PGNY): questions and answers

What is PGNY's P/E ratio?

Progyny, Inc. trades at 33.7× its last twelve months' earnings and 15.3× next year's expected earnings. At its fiscal year-ends over the past 6 years the P/E ranged from 30.3× to 103.8×, with a median of 68.1×.

What is Progyny, Inc.'s market cap?

Progyny, Inc. is valued at $2.7B at a share price of $36.71.

Is PGNY overvalued or undervalued?

Against its own history, PGNY is well below its usual price: the price is 36% below the $56.97 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is PGNY above its 200-week moving average?

Yes. PGNY is 34.6% above its 200-week average of $27.27. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Progyny, Inc. growing?

Over the last five fiscal years Progyny, Inc.'s revenue grew 30.2% a year and its earnings per share 6.7% a year.

Does PGNY pay a dividend?

Progyny, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Progyny, Inc. (PGNY) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/PGNY

Underlying data: Yahoo Finance; company filings with the SEC.